Sartorius Stedim Biotech S.A. (EPA:DIM)
174.70
+3.50 (2.04%)
May 28, 2026, 5:35 PM CET
Sartorius Stedim Biotech Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains €210.00 | Buy | Maintains | €210.00 | +20.21% | May 6, 2026 |
| Barclays | Barclays | Buy Maintains €220.00 | Buy | Maintains | €220.00 | +25.93% | Apr 23, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains €260.00 | Buy | Maintains | €260.00 | +48.83% | Apr 23, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains €214.00 | Buy | Maintains | €214.00 | +22.50% | Apr 23, 2026 |
| UBS | UBS | Hold Maintains €220.00 | Hold | Maintains | €220.00 | +25.93% | Apr 17, 2026 |
| Kepler Capital | Kepler Capital | Buy Upgrades n/a | Buy | Upgrades | n/a | n/a | Mar 18, 2026 |
| Jefferies | Jefferies | Buy Maintains €256.00 → €262.00 | Buy | Maintains | €256.00 → €262.00 | +49.97% | Mar 17, 2026 |
| Bernstein | Bernstein | Buy Maintains €245.00 | Buy | Maintains | €245.00 | +40.24% | Mar 16, 2026 |